Mohamad Makhzoumi's Net Worth

$167 Million

Who is Mohamad Makhzoumi?

Mohamad Makhzoumi has an estimated net worth of $167 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., AVEO PHARMACEUTICALS, INC., Mirum Pharmaceuticals, Inc., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Annexon, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., Senti Biosciences, Inc.\, Achaogen Inc, and Korro Bio, Inc..

SEC CIK

Mohamad Makhzoumi's CIK is 0001630226

Past Insider Trading and Trends

2021 was Mohamad Makhzoumi's most active year for acquiring shares with 42 total transactions. Mohamad Makhzoumi's most active month to acquire stocks was the month of May. 2021 was Mohamad Makhzoumi's most active year for disposing of shares, totalling 37 transactions. Mohamad Makhzoumi's most active month to dispose stocks was the month of May. 2022 saw Mohamad Makhzoumi paying a total of $378,949,994.40 for 18,705,265 shares, this is the most they've acquired in one year. In 2019 Mohamad Makhzoumi cashed out on 53,651,792 shares for a total of $169,894,566.00, their largest year based on trade value.